Growth Investment Partners Ghana backs pharmacy player
More than half of the funding is earmarked for expansion in Francophone West Africa.
** For the best experience, download the free Africa Private Equity News app Android | iOS **
Growth Investment Partners (GIP) Ghana – an investment platform established by British International Investment – has made an investment into mPharma Ghana.
The investment will support mPharma’s plan to extend its QualityRx franchise model into Francophone markets, including Togo and Benin, and improve inventory efficiency across its growing multi-pharmacy network. More than half of the funding is earmarked for expansion in Francophone West Africa, where the company sees growing demand for reliable, affordable pharmaceutical services.
Founded in 2013, mPharma has become one of Africa’s leading health-tech firms by tackling the persistent challenge of medicine affordability. The company’s asset-light franchise model enables independent pharmacies to operate under its Mutti brand, using proprietary software to manage inventory, pricing, and supply chains more efficiently.
“Our goal is to back enterprises that improve essential services for ordinary people. The expansion will help communities gain better access to quality medicines while supporting the resilience of local health systems,” said Jacob Kholi, chief executive and investment officer, GIP Ghana.
“Access to affordable medicines remains one of the most pressing healthcare challenges in Africa. With GIP’s support, we can scale our partnerships with pharmacies and healthcare providers to ensure equitable access to quality care across Ghana and Francophone West Africa,” said Kwesi Arhin, chief executive officer of mPharma.
Want to know who is raising, investing, and exiting in Africa? Get Africa Private Equity News’ monthly Dealmaker’s Log – a database of reported investment deals, exits, and fundraising closes. Subscribe now